Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,508 INR | +1.34% | -1.12% | -0.46% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The group's high margin levels account for strong profits.
- The company is in a robust financial situation considering its net cash and margin position.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 29.61 and 26.92 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.33 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.46% | 2.93B | C+ | ||
+15.82% | 38.79B | C | ||
-.--% | 10.98B | - | B+ | |
-4.50% | 7.52B | A | ||
+3.29% | 6.81B | B- | ||
-3.91% | 6B | B+ | ||
-10.77% | 5.59B | - | C- | |
-3.96% | 5.66B | B | ||
+33.14% | 5.26B | B- | ||
-13.04% | 4.56B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- BAYERCROP Stock
- Ratings Bayer CropScience Limited